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Dear Reader,
As we approach the end of 2015, and publish our final issue of Drugs—Real World Outcomes for the year, the editors and
production staff at Adis wish to reflect on another successful year’s achievements and pay thanks to all those who have
contributed their time and effort to guarantee the exceptional quality of our content.
We are delighted to have seen the conclusion of formalities surrounding the joint venture between Springer
Science ? Business Media with Nature Publishing Group, Palgrave Macmillan, Macmillan Education in early May.
Substantial ground has already been made in the integration of business within the resulting Springer Nature company and
we at Adis look eagerly toward the future, as the benefits of the collective expertise and capabilities of this company carry
us forward.
The majority of our journals saw a rise in ISI impact factor against the previous year. Most notably, BioDrugs increased
by 41 % to 2.989; the European Journal of Drug Metabolism and Pharmacokinetics increased 19 % to 1.563; CNS Drugs
increased by 17 % to 5.113; Targeted Oncology increased 16 % to 4.000; Pediatric Drugs increased 15 % to 1.975; Drugs
& Aging increased 13 % to 2.838; and Molecular Diagnosis & Therapy increased a further 12 % to 2.891, having already
jumped 53 % in the preceding year. We hope to build upon these gains, once more, in 2016.
The Adis Book programme has grown substantially and 20 new titles will have been published over the course of the
year. Over 50 further titles are currently in development with leading academics, internationally, and we continue to add
more to the list. Our thanks, again, to all who have submitted these valuable proposals to date.
We offer our sincere thanks to all authors who have contributed articles to Drugs—Real World Outcomes since its
inception in October 2014. Their skill and dedication are critical to the continued publication of the journal. The world-
class quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment
ensures that our content is held to the highest possible standard. In addition to the members of our Honorary Editorial
Board, we would like to thank the following individuals who acted as reviewers for articles published in Drugs—Real
World Outcomes in 2015:
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David M Mannino, USA
Nariman Ahmad Mansur, Israel
Milka Maravic, France










Bjorn Erik Neerland, Norway
Dave Nellesen, USA
Tuan Anh Nguyen, Australia
Prasad S Nishtala, New Zealand
Rebecca Noel, USA
Kenneth Nugent, USA
Alexandra Cristina Pacurariu, The Netherlands
William Vincent Padula, USA
Lynne Parkinson, Australia




















Petra A Thurmann, Germany
Philippe Tuppin, France
Eric van Ganse, France
Florence van Hunsel, The Netherlands













We hope that you have found the articles published throughout 2015 to be both interesting and informative. The editors
have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date
with topical issues in the field of real world and big data in 2016.
With best wishes from the staff of Drugs—Real World Outcomes and all at Adis Publications.
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